Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Repurchased
Ratios

GE HealthCare Technologies (GEHC) EBIAT (2022 - 2025)

GE HealthCare Technologies (GEHC) has disclosed EBIAT for 4 consecutive years, with $601.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EBIAT fell 11.75% year-over-year to $601.0 million, compared with a TTM value of $2.1 billion through Dec 2025, up 6.5%, and an annual FY2025 reading of $2.1 billion, up 4.57% over the prior year.
  • EBIAT was $601.0 million for Q4 2025 at GE HealthCare Technologies, up from $465.0 million in the prior quarter.
  • Across five years, EBIAT topped out at $681.0 million in Q4 2024 and bottomed at $382.0 million in Q3 2023.
  • Average EBIAT over 4 years is $481.9 million, with a median of $475.0 million recorded in 2025.
  • The sharpest move saw EBIAT dropped 24.19% in 2023, then skyrocketed 53.03% in 2024.
  • Year by year, EBIAT stood at $587.0 million in 2022, then decreased by 24.19% to $445.0 million in 2023, then surged by 53.03% to $681.0 million in 2024, then dropped by 11.75% to $601.0 million in 2025.
  • Business Quant data shows EBIAT for GEHC at $601.0 million in Q4 2025, $465.0 million in Q3 2025, and $485.0 million in Q2 2025.